Octreotide inhibits the secretion of interleukin-12 from mononuclear cells in human peripheral blood (PBMCs) in vitro

Hormone and Metabolic Research

Volumn 33, Issue 11, 2001, Pages 689-690

  Komorowski, J ^a   Jankiewicz Wika, J ^a   Stepien T ^a   Kuzdak, K ^a   Stepien H ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; OCTREOTIDE;

ADULT; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IN VITRO STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL;

ADULT; HORMONES; HUMANS; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; OCTREOTIDE;

EID: 0035217729     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-18684     Document Type: Article

References (10)

1. Matrix metalloproteinase inhibition. From the Jurassic to the third millennium
2. Effect of somatostatin and octreotide on proliferation and vascular endothelial growth factor secretion from murine endothelial cell line (HECa10) culture
3. Somatostatin (SOM) and octreotide (OCT) inhibit the secretion of interleukin-8 (IL-8) from human peripheral blood mononuclear cells (PBMC) in vitro
4. Inhibition of angiogenesis in vivo by interleukin-12
5. Somatostatin analogs: Angiogenesis inhibitors with novel mechanisms of action
6. Expression of somatostatin receptor subtype 2 mRNA in human lymphoid cells
7. Somatostatin (SRIF) stimulates the release of interleukin-6 (IL-6) from human peripheral blood monocytes (PBM) in vitro
8. Interleukin-12
9. Danazol and multiple hepatic adenomas: Peculiar clinical findings in an acromegalic patient